nct_id,title,sponsor,sponsor_class,phase,status,completion_date,condition,ticker,market_cap,current_price,pct_change_30d,days_to_catalyst
NCT04348747,Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer,Roswell Park Cancer Institute,OTHER,Phase 2,RECRUITING,2025-12-15,"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Metastatic Triple-Negative Breast Carcinoma","(None, 0)",,,0.0,1
NCT03466294,Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML,"University of Colorado, Denver",OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-15,Acute Myeloid Leukemia,"(None, 0)",,,0.0,1
NCT04010448,"A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India",PATH,OTHER,Phase 3,RECRUITING,2025-12-15,Rotavirus Infection of Children,"(None, 0)",,,0.0,1
NCT04572815,Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant,Fred Hutchinson Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-16,"Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm","(None, 0)",,,0.0,2
NCT05599191,A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough,Bellus Health Inc. - a GSK company,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2025-12-18,"Cough, Refractory Chronic Cough","(None, 0)",,,0.0,4
NCT06861010,Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis,Tanta University,OTHER,Phase 3,RECRUITING,2025-12-20,Pancreatic Diseases,"(None, 0)",,,0.0,6
NCT04644016,Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders,Memorial Sloan Kettering Cancer Center,OTHER,Phase 2,RECRUITING,2025-12-20,"AML, ALL, MDS","(None, 0)",,,0.0,6
NCT06176885,Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer,yue junhan,OTHER,Phase 2,RECRUITING,2025-12-20,Colorectal Cancer,"(None, 0)",,,0.0,6
NCT05731726,Serplulimab Combined with CAPEOX + Celecoxib As Neoadjuvant Treatment for Locally Advanced Rectal Cancer,Zhejiang University,OTHER,Phase 2,RECRUITING,2025-12-20,"PMMR, MSS, MSI-L","(None, 0)",,,0.0,6
NCT06444620,B/F/TAF to DTG/3TC Switch Study,University of Nairobi,OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2025-12-22,HIV-1-infection,"(None, 0)",,,0.0,8
NCT05824871,A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients,"Shanghai Jiatan Pharmatech Co., Ltd",INDUSTRY,Phase 3,RECRUITING,2025-12-22,"Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)","(None, 0)",,,0.0,8
NCT03996265,Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors,University of Rochester NCORP Research Base,OTHER,Phase 3,RECRUITING,2025-12-23,"Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm","('RHHBY', 100)",,,0.0,9
NCT05179733,The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years,Ruijin Hospital,OTHER,Phase 3,RECRUITING,2025-12-25,Diffuse Large B-Cell Lymphoma,"(None, 0)",,,0.0,11
NCT05027386,"Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.",Sun Yat-sen University,OTHER,Phase 2,RECRUITING,2025-12-26,Neuroblastoma,"(None, 0)",,,0.0,12
NCT05746039,Feasibility of Semaglutide in Advanced Lung Disease,University of Pennsylvania,OTHER,Phase 2,RECRUITING,2025-12-28,"Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease","(None, 0)",,,0.0,14
NCT04302324,"A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab",Weill Medical College of Cornell University,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-28,"Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma","(None, 0)",,,0.0,14
NCT07169383,Oral Melatonin Versus Oral Tranexamic Acid in the Management of Melasma,Hina Malik,OTHER,Phase 2,ENROLLING_BY_INVITATION,2025-12-28,Melasma (Facial Melasma),"(None, 0)",,,0.0,14
NCT05035836,A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC),M.D. Anderson Cancer Center,OTHER,Phase 2,RECRUITING,2025-12-29,"Breast Cancer, HER2-positive","(None, 0)",,,0.0,15
NCT06594146,Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP),Keymed Biosciences Co.Ltd,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-30,Primary Immune Thrombocytopenia,"(None, 0)",,,0.0,16
NCT05835245,Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free),Fudan University,OTHER,Phase 2,RECRUITING,2025-12-30,Advanced Intrahepatic Cholangiocarcinoma,"(None, 0)",,,0.0,16
NCT05930210,A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer,"Energenesis Biomedical Co., Ltd.",INDUSTRY,Phase 3,RECRUITING,2025-12-30,"Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus","(None, 0)",,,0.0,16
NCT05897268,Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10),Fudan University,OTHER,Phase 2,RECRUITING,2025-12-30,Hepatocellular Carcinoma,"(None, 0)",,,0.0,16
NCT06891040,Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis,"Jiangsu vcare pharmaceutical technology co., LTD",INDUSTRY,Phase 2,RECRUITING,2025-12-30,Atopic Dermatitis,"(None, 0)",,,0.0,16
NCT06972511,Maximal Tumor Eradication for Oligometastatic Prostate Cancer,RenJi Hospital,OTHER,Phase 3,RECRUITING,2025-12-30,Oligometastatic Prostate Cancer,"(None, 0)",,,0.0,16
NCT06784648,"Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma",BioInvent International AB,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-30,"Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E/K Mutated","(None, 0)",,,0.0,16
NCT03463252,Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC,West China Second University Hospital,OTHER,Phase 3,RECRUITING,2025-12-30,"Endometrial Cancer, Atypical Endometrial Hyperplasia","(None, 0)",,,0.0,16
NCT04386317,Terazosin Effect on Cardiac Changes in Early Parkinson's Disease,Cedars-Sinai Medical Center,OTHER,Phase 2,RECRUITING,2025-12-30,"REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease","(None, 0)",,,0.0,16
NCT06441565,Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer,Sun Yat-sen University,OTHER,Phase 3,RECRUITING,2025-12-30,Colorectal Cancer,"(None, 0)",,,0.0,16
NCT03641456,VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma,Sun Yat-sen University,OTHER,Phase 2,RECRUITING,2025-12-30,"Myeloma, Newly Diagnosed, High Risk","(None, 0)",,,0.0,16
NCT03683225,A Study to Evaluate in Patients With Parkinsonian Type Disorders,Chase Therapeutics Corporation,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-30,Idiopathic Parkinson Disease,"(None, 0)",,,0.0,16
NCT05781074,Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）,Fudan University,OTHER,Phase 2,RECRUITING,2025-12-30,Advanced Biliary Tract Cancer,"(None, 0)",,,0.0,16
NCT06032845,Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11),Fudan University,OTHER,Phase 2,RECRUITING,2025-12-30,"Solid Tumor, Adult","(None, 0)",,,0.0,16
NCT03611868,A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors,Ascentage Pharma Group Inc.,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-30,"Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma","(None, 0)",,,0.0,16
NCT05431413,Rapid Improvement of Depression of Fluoxetine Combined With ATP,"Nanfang Hospital, Southern Medical University",OTHER,Phase 2,RECRUITING,2025-12-30,Depression,"(None, 0)",,,0.0,16
NCT02313194,Spinal Cord Neuromodulation for Spinal Cord Injury,"University of California, Los Angeles",OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-30,"Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia","(None, 0)",,,0.0,16
NCT06209294,Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery,Xiaohua Wu,OTHER,Phase 2,RECRUITING,2025-12-30,"Neoadjuvant Immunotherapy, Cervical Cancer, Fertility-sparing Surgery","(None, 0)",,,0.0,16
NCT04589754,Adriamycin and Ifosfamide Combined With Sintilimab,Sun Yat-sen University,OTHER,Phase 2,RECRUITING,2025-12-30,Soft Tissue Sarcoma,"(None, 0)",,,0.0,16
NCT04214067,"Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer",National Cancer Institute (NCI),NIH,Phase 3,ACTIVE_NOT_RECRUITING,2025-12-30,"Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8, Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8","(None, 0)",,,0.0,16
NCT04150744,RFA Plus Carrizumab vs Carrizumab Alone for HCC,"Second Affiliated Hospital, School of Medicine, Zhejiang University",OTHER,Phase 2,RECRUITING,2025-12-30,"Tumor Immunity, Immunosuppression, Radiofrequency Ablation","(None, 0)",,,0.0,16
NCT06123754,Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC,"3D Medicines (Sichuan) Co., Ltd.",INDUSTRY,Phase 3,RECRUITING,2025-12-30,Non-small Cell Lung Cancer,"(None, 0)",,,0.0,16
NCT06366698,Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia,Arrowhead Regional Medical Center,OTHER,Phase 3,RECRUITING,2025-12-30,Iron Deficiency Anemia of Pregnancy,"(None, 0)",,,0.0,16
NCT04430699,Cisplatin+Pembrolizumab+RT in Vulvar Cancer,Massachusetts General Hospital,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-30,"Vulvar Cancer, Vulvar Squamous Cell Carcinoma","(None, 0)",,,0.0,16
NCT04594850,Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously,"Pharmicell Co., Ltd.",INDUSTRY,Phase 2,RECRUITING,2025-12-31,Erectile Dysfunction,"(None, 0)",,,0.0,17
NCT04516135,Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers,M.D. Anderson Cancer Center,OTHER,Phase 2,RECRUITING,2025-12-31,Metastatic Malignant Female Reproductive System Neoplasm,"(None, 0)",,,0.0,17
NCT05884320,Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers,M.D. Anderson Cancer Center,OTHER,Phase 2,RECRUITING,2025-12-31,"Gland, Salivary Gland Cancers","(None, 0)",,,0.0,17
NCT02568267,"Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)",Hoffmann-La Roche,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Breast Cancer, Cholangiocarcinoma, Colorectal Cancer","('RHHBY', 100)",,,0.0,17
NCT06706713,Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer,BeBetter Med Inc,INDUSTRY,Phase 2,RECRUITING,2025-12-31,"Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation","(None, 0)",,,0.0,17
NCT06143748,Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006),Sun Yat-sen University,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,Esophagus Cancer,"(None, 0)",,,0.0,17
NCT04486781,A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma,"Vasgene Therapeutics, Inc",INDUSTRY,Phase 2,RECRUITING,2025-12-31,Metastatic Urothelial Carcinoma,"('VYGR', 88)",,,0.0,17
NCT04305548,Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma,Italian Sarcoma Group,NETWORK,Phase 2,RECRUITING,2025-12-31,Mesenchymal Chondrosarcoma,"(None, 0)",,,0.0,17
NCT05260957,"CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).",Lazaros Lekakis,OTHER,Phase 2,RECRUITING,2025-12-31,"Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma","(None, 0)",,,0.0,17
NCT02148796,Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness,University of Arizona,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Asthma, Wheezing","(None, 0)",,,0.0,17
NCT05768997,High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia,Hallym University Medical Center,OTHER,Phase 3,RECRUITING,2025-12-31,Anemia,"(None, 0)",,,0.0,17
NCT03565783,Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery,M.D. Anderson Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck, Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","(None, 0)",,,0.0,17
NCT06267001,A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy,Hoffmann-La Roche,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2025-12-31,Non-small Cell Lung Cancer (NSCLC),"('RHHBY', 100)",,,0.0,17
NCT04680026,A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF),"HUYABIO International, LLC.",INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,Atrial Fibrillation,"(None, 0)",,,0.0,17
NCT04680442,Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction,Population Health Research Institute,OTHER,Phase 2,RECRUITING,2025-12-31,"Breast Cancer, Heart Failure","(None, 0)",,,0.0,17
NCT05058287,Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression,"Hospital for Special Surgery, New York",OTHER,Phase 3,RECRUITING,2025-12-31,"Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative","(None, 0)",,,0.0,17
NCT05669092,A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status,Zhejiang Cancer Hospital,OTHER,Phase 3,RECRUITING,2025-12-31,"Toripalimab, Radiation","(None, 0)",,,0.0,17
NCT03814317,Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension,University of Florida,OTHER,Phase 2,RECRUITING,2025-12-31,"Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease","(None, 0)",,,0.0,17
NCT06171555,Efficacy of CTM for Tennis ELbow,Indiana Hand to Shoulder Center,OTHER,Phase 2,ENROLLING_BY_INVITATION,2025-12-31,"Tennis Elbow, Lateral Epicondylitis \(Tennis Elbow\), Lateral Elbow Tendinopathy","(None, 0)",,,0.0,17
NCT06540352,"A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form","National Medical Research Center for Cardiology, Ministry of Health of Russian Federation",OTHER_GOV,Phase 2,RECRUITING,2025-12-31,"Atrial Fibrillation, Atrial Flutter","(None, 0)",,,0.0,17
NCT06422858,Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma,Zhejiang Cancer Hospital,OTHER,Phase 2,RECRUITING,2025-12-31,Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma,"(None, 0)",,,0.0,17
NCT05077800,FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer,"Colin D. Weekes, M.D., PhD",OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic","(None, 0)",,,0.0,17
NCT04522544,Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC,Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,OTHER,Phase 2,RECRUITING,2025-12-31,"Hepatocellular Carcinoma Non-resectable, HCC","(None, 0)",,,0.0,17
NCT06737081,SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies,"Shenzhen Salubris Pharmaceuticals Co., Ltd.",INDUSTRY,Phase 2,RECRUITING,2025-12-31,Anemia,"(None, 0)",,,0.0,17
NCT06135350,Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",OTHER,Phase 2,RECRUITING,2025-12-31,"Gram Negative Pneumonia, Gram-Negative Bacterial Infections, Bacteremia Caused by Gram-Negative Bacteria","(None, 0)",,,0.0,17
NCT05681260,Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children with Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL),"Children's Cancer Group, China",NETWORK,Phase 3,RECRUITING,2025-12-31,T-cell Lymphoblastic Lymphoma,"(None, 0)",,,0.0,17
NCT03977493,IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia,Alain Kaelin,OTHER,Phase 3,RECRUITING,2025-12-31,Focal Hand Dystonia,"(None, 0)",,,0.0,17
NCT05926960,"A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma",Pfizer,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,Melanoma,"('PFE', 100)",,,0.0,17
NCT05975307,Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation,Sun Yat-sen University,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy","(None, 0)",,,0.0,17
NCT06829355,"""Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer""",Beijing Friendship Hospital,OTHER,Phase 2,RECRUITING,2025-12-31,MCRC,"(None, 0)",,,0.0,17
NCT03854032,Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck,Thomas Jefferson University,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx","(None, 0)",,,0.0,17
NCT05299554,Long-term Safety Study of Chronocort in the Treatment of Participants with Congenital Adrenal Hyperplasia,Neurocrine UK Limited,INDUSTRY,Phase 3,ENROLLING_BY_INVITATION,2025-12-31,Congenital Adrenal Hyperplasia,"(None, 0)",,,0.0,17
NCT07163819,Effect of Probiotic Intervention on Travel-Related Health Conditions During Short-Term Overseas Travel,Universiti Sains Malaysia,OTHER,Phase 2,RECRUITING,2025-12-31,Healthy Adults,"(None, 0)",,,0.0,17
NCT04523493,Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC,"Shanghai Junshi Bioscience Co., Ltd.",OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2025-12-31,Advanced Hepatocellular Carcinoma (HCC),"(None, 0)",,,0.0,17
NCT04115163,Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer,Anne Noonan,OTHER,Phase 2,RECRUITING,2025-12-31,"Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8","(None, 0)",,,0.0,17
NCT03508232,Doxycycline to Protect Heart Muscle After Heart Attacks,University of Alberta,OTHER,Phase 2,RECRUITING,2025-12-31,"ST Segment Elevation Myocardial Infarction, Heart Failure","(None, 0)",,,0.0,17
NCT06341595,Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM,The First Affiliated Hospital with Nanjing Medical University,OTHER,Phase 2,RECRUITING,2025-12-31,"Gastric Cancer, Gastric Cancer Metastatic to Regional Lymph Nodes","(None, 0)",,,0.0,17
NCT06173817,The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients,Oslo University Hospital,OTHER,Phase 3,RECRUITING,2025-12-31,Methanol Poisoning,"(None, 0)",,,0.0,17
NCT03937830,"Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma",National Cancer Institute (NCI),NIH,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma","(None, 0)",,,0.0,17
NCT06404099,"RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)",Duke University,OTHER,Phase 2,RECRUITING,2025-12-31,"Long COVID, Long COVID-19, Hypersomnia","(None, 0)",,,0.0,17
NCT06157502,Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY),Beijing Tiantan Hospital,OTHER,Phase 3,RECRUITING,2025-12-31,"Ischemic Stroke, Acute","(None, 0)",,,0.0,17
NCT05619302,Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis,Brigham and Women's Hospital,OTHER,Phase 3,RECRUITING,2025-12-31,Cardiac Amyloidosis,"(None, 0)",,,0.0,17
NCT05056402,An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old,Xiamen University,OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2025-12-31,"Cervical Cancer, Condylomata Acuminata","(None, 0)",,,0.0,17
NCT06705530,"A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders","National Research Center for Hematology, Russia",NETWORK,Phase 2,RECRUITING,2025-12-31,"Non-Hodgkin Lymphoma, B-cell, Acute Lymphoblastic Leukemia ALL","(None, 0)",,,0.0,17
NCT04905056,"A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules",Shanghai Zhongshan Hospital,OTHER,Phase 2,RECRUITING,2025-12-31,Progression,"(None, 0)",,,0.0,17
NCT04560673,Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy,M.D. Anderson Cancer Center,OTHER,Phase 2,RECRUITING,2025-12-31,"Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","(None, 0)",,,0.0,17
NCT06055244,Amantadine Therapy for Cognitive Impairment in Long COVID,Ohio State University,OTHER,Phase 2,RECRUITING,2025-12-31,"Long COVID, Post-COVID19 Condition, Post-Acute COVID19 Syndrome","(None, 0)",,,0.0,17
NCT06410651,Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",OTHER,Phase 2,RECRUITING,2025-12-31,"Esophageal Cancer, Nimotuzumab, Chemoradiotherapy","(None, 0)",,,0.0,17
NCT00488072,Effects of Mirtazapine on Appetite in Advanced Cancer Patients,M.D. Anderson Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Advanced Cancer, Anorexia, Weight Loss","(None, 0)",,,0.0,17
NCT01587352,Vorinostat in Treating Patients With Metastatic Melanoma of the Eye,National Cancer Institute (NCI),NIH,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7","(None, 0)",,,0.0,17
NCT05253118,Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS),Seoul National University Hospital,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,DLBCL,"(None, 0)",,,0.0,17
NCT06004856,Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia,"Beijing InnoCare Pharma Tech Co., Ltd.",INDUSTRY,Phase 3,RECRUITING,2025-12-31,Chronic Primary Immune Thrombocytopenia (ITP),"(None, 0)",,,0.0,17
NCT04331041,Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma,Washington University School of Medicine,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2025-12-31,"Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma","(None, 0)",,,0.0,17
NCT05178992,Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy,Vanderbilt University,OTHER,Phase 2,RECRUITING,2025-12-31,Alzheimer Disease,"(None, 0)",,,0.0,17
NCT05438368,GD2/CD70 Bi-specific CAR-T Cell Therapy,Shenzhen Geno-Immune Medical Institute,OTHER,Phase 2,RECRUITING,2025-12-31,Cancer Disease,"(None, 0)",,,0.0,17
NCT06348602,Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT,Hospital Universitario Dr. Jose E. Gonzalez,OTHER,Phase 2,RECRUITING,2025-12-31,Ocular Graft-versus-host Disease,"(None, 0)",,,0.0,17
NCT04452500,Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study),VA Office of Research and Development,FED,Phase 2,RECRUITING,2025-12-31,PTSD,"(None, 0)",,,0.0,17
NCT05464784,"MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia",MediciNova,INDUSTRY,Phase 2,RECRUITING,2025-12-31,"Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease","(None, 0)",,,0.0,17
NCT05104983,Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study,Darcy Krueger,OTHER,Phase 2,RECRUITING,2025-12-31,"Tuberous Sclerosis Complex, Epilepsy","(None, 0)",,,0.0,17
NCT03109288,"Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)",National Institute of Allergy and Infectious Diseases (NIAID),NIH,Phase 2,RECRUITING,2026-01-01,Multiple Sclerosis,"(None, 0)",,,0.0,18
NCT06448052,Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation,Nguyen Ton Ngoc Huynh,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-01,"Inflammatory Disease, Aging Problems, Obese","(None, 0)",,,0.0,18
NCT05968937,Vaginal Baclofen Suppositories in Chronic Pelvic Pain,University of Louisville,OTHER,Phase 2,RECRUITING,2026-01-01,Chronic Pelvic Pain Syndrome,"(None, 0)",,,0.0,18
NCT07073287,Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients,Universidade Federal de Pernambuco,OTHER,Phase 2,RECRUITING,2026-01-01,"Stroke Rehabilitation, Gait Disorders, Neurologic, tDCS","(None, 0)",,,0.0,18
NCT06762080,Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis,Guangzhou Medical University,OTHER,Phase 2,RECRUITING,2026-01-01,Leptomeningeal Metastasis,"(None, 0)",,,0.0,18
NCT05907057,An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.,Servier Affaires Médicales,INDUSTRY,Phase 3,RECRUITING,2026-01-01,Acute Myeloid Leukemia (AML),"(None, 0)",,,0.0,18
NCT04160910,5HTP Regulation Of Asthma In Children,Indiana University,OTHER,Phase 2,RECRUITING,2026-01-05,Mild or Moderate Asthma With Allergic Sensitization,"(None, 0)",,,0.0,22
NCT05303532,Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab,AstraZeneca,INDUSTRY,Phase 3,ENROLLING_BY_INVITATION,2026-01-07,Cancer,"('AZN', 100)",,,0.0,24
NCT05419050,Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia,National Institute of Dental and Craniofacial Research (NIDCR),NIH,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-09,Fibrous Dysplasia,"(None, 0)",,,0.0,26
NCT05978037,A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines,University of Oxford,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-10,"Malaria, Malaria,Falciparum, Parasitic Disease","(None, 0)",,,0.0,27
NCT02684292,Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204),Merck Sharp & Dohme LLC,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-01-12,Hodgkin Lymphoma,"('MRK', 100)",,,0.0,29
NCT05767359,CAR- PRISM (PRecision Intervention Smoldering Myeloma),Dana-Farber Cancer Institute,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-15,"Multiple Myeloma, Smoldering Multiple Myeloma","(None, 0)",,,0.0,32
NCT07096310,Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients,Ain Shams University,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-15,Sepsis,"(None, 0)",,,0.0,32
NCT01409200,Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis,M.D. Anderson Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-15,"Metastatic Malignant Neoplasm in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7","(None, 0)",,,0.0,32
NCT02940301,Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma,Ohio State University Comprehensive Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-15,Classical Hodgkin Lymphoma,"(None, 0)",,,0.0,32
NCT01684397,Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer,Roswell Park Cancer Institute,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-20,"Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer","(None, 0)",,,0.0,37
NCT05564403,"Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)",National Cancer Institute (NCI),NIH,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-21,"Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, Advanced Intrahepatic Cholangiocarcinoma","(None, 0)",,,0.0,38
NCT05672368,The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures,City of Hope Medical Center,OTHER,Phase 2,RECRUITING,2026-01-27,Disease or Disorder,"(None, 0)",,,0.0,44
NCT05399654,A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors,Tallac Therapeutics,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-27,Advanced or Metastatic Solid Tumors,"('CARA', 80)",,,0.0,44
NCT06839664,A Study of HS-20094 in Chinese Adults with Overweight or Obesity,"Jiangsu Hansoh Pharmaceutical Co., Ltd.",INDUSTRY,Phase 3,RECRUITING,2026-01-27,"Overweight, Obesity","(None, 0)",,,0.0,44
NCT05489289,A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection,Akeso,INDUSTRY,Phase 3,RECRUITING,2026-01-28,Hepatocellular Carcinoma,"(None, 0)",,,0.0,45
NCT05251259,Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma,AstraZeneca,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-29,Asthma,"('AZN', 100)",,,0.0,46
NCT06490081,Trilaciclib Prevents Myelosuppression With Chemoradiotherapy,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",OTHER,Phase 2,RECRUITING,2026-01-30,Myelosuppression,"(None, 0)",,,0.0,47
NCT06616389,Study of ODX (OsteoDex) in Multiple Myeloma,DexTech Medical AB,INDUSTRY,Phase 2,RECRUITING,2026-01-30,Multiple Myeloma,"(None, 0)",,,0.0,47
NCT04460872,Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury,North Florida Foundation for Research and Education,OTHER,Phase 2,RECRUITING,2026-01-30,"Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System","(None, 0)",,,0.0,47
NCT05438043,A Study of Daratumumab,"Janssen Research & Development, LLC",INDUSTRY,Phase 3,RECRUITING,2026-01-30,Multiple Myeloma,"(None, 0)",,,0.0,47
NCT07167550,The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke,"Tatchempharmpreparaty, JSC",INDUSTRY,Phase 3,RECRUITING,2026-01-31,"Stroke, Acute Stroke, Ischemic Stroke","(None, 0)",,,0.0,48
NCT06793332,BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC,Fudan University,OTHER,Phase 2,RECRUITING,2026-01-31,"Triple-Negative Breast Cancer (TNBC), Brain Metastases","(None, 0)",,,0.0,48
NCT01344200,CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children,Children's Hospital of Eastern Ontario,OTHER,Phase 2,RECRUITING,2026-01-31,Pharmacokinetics of Celecoxib in Children,"(None, 0)",,,0.0,48
NCT05357482,Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-31,"Sickle Cell Anemia, Beta Thalassemia","(None, 0)",,,0.0,48
NCT04820179,"Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer",University of Arizona,OTHER,Phase 2,RECRUITING,2026-01-31,"Pancreatic Cancer, Metastatic Pancreatic Cancer","(None, 0)",,,0.0,48
NCT06084819,Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia,Chinese PLA General Hospital,OTHER,Phase 2,RECRUITING,2026-01-31,Relapsed/Refractory Acute Myeloid Leukemia,"(None, 0)",,,0.0,48
NCT06046443,A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity,"Rhythm Pharmaceuticals, Inc.",INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-01-31,Hypothalamic Obesity,"('PHAT', 91)",,,0.0,48
NCT06210971,Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer,Hebei Medical University Fourth Hospital,OTHER,Phase 2,RECRUITING,2026-02-01,Rectal Cancer,"(None, 0)",,,0.0,49
NCT02884648,Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery,M.D. Anderson Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-02-01,"Malignant Neoplasms of Female Genital Organs, Ovarian Cancer, Fallopian Tube Cancer","(None, 0)",,,0.0,49
NCT04620187,Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas,Dana-Farber Cancer Institute,OTHER,Phase 2,RECRUITING,2026-02-01,"Salivary Gland Cancer, HER2 Gene Mutation","(None, 0)",,,0.0,49
NCT06241599,"A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)",Sun Yat-sen University,OTHER,Phase 3,RECRUITING,2026-02-01,Recurrent or Metastatic Nasopharyngeal Carcinoma,"(None, 0)",,,0.0,49
NCT05726396,A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis,University of Minnesota,OTHER,Phase 2,RECRUITING,2026-02-01,"Immune-related Colitis, Colitis","(None, 0)",,,0.0,49
NCT04551807,Natural Versus Programmed Frozen Embryo Transfer (NatPro),JHSPH Center for Clinical Trials,OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2026-02-01,"Pregnancy Related, Pre-Eclampsia","(None, 0)",,,0.0,49
NCT06253130,"A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors",Eikon Therapeutics,INDUSTRY,Phase 2,RECRUITING,2026-02-01,Advanced Solid Tumor,"('BEAM', 82)",,,0.0,49
NCT06248619,A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease,Amgen,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-02-10,Thyroid Eye Disease,"('AMGN', 100)",,,0.0,58
NCT04586231,A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011),Merck Sharp & Dohme LLC,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-02-11,"Carcinoma, Renal Cell","('MRK', 100)",,,0.0,59
NCT07036601,Phase II Study of THDBH120 Injection in Overweight or Obese Subjects,"Tonghua Dongbao Pharmaceutical Co.,Ltd",INDUSTRY,Phase 2,RECRUITING,2026-02-13,Overweight or Obese,"(None, 0)",,,0.0,61
NCT06037889,Efficacy and Safety of Tirofiban for Patients With BAD (BRANT),Peking Union Medical College Hospital,OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2026-02-22,Branch Atheromatous Disease,"(None, 0)",,,0.0,70
NCT06299826,A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure,AstraZeneca,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-02-24,Chronic Heart Failure,"('AZN', 100)",,,0.0,72
NCT05605496,NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies,Centre Leon Berard,OTHER,Phase 2,RECRUITING,2026-02-24,"Advanced Solid Tumors, Metastatic Solid Tumors","(None, 0)",,,0.0,72
NCT05589896,A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies,"Ossium Health, Inc.",INDUSTRY,Phase 2,RECRUITING,2026-02-25,"Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","(None, 0)",,,0.0,73
NCT04777851,Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7,Translational Research in Oncology,OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2026-02-28,"Carcinoma, Hepatocellular","(None, 0)",,,0.0,76
NCT02816021,Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma,M.D. Anderson Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-02-28,"Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma","(None, 0)",,,0.0,76
NCT06368141,Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer,Ruijin Hospital,OTHER,Phase 2,RECRUITING,2026-02-28,Colon Cancer,"(None, 0)",,,0.0,76
NCT05132075,Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer,Novartis Pharmaceuticals,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-02-28,Non-Small Cell Lung Cancer,"('NVS', 100)",,,0.0,76
NCT05951049,A Study of AT-02 in Subjects With Systemic Amyloidosis.,"Attralus, Inc.",INDUSTRY,Phase 2,RECRUITING,2026-02-28,Amyloidosis; Systemic,"(None, 0)",,,0.0,76
NCT04056533,Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy,Instituto de Investigación Marqués de Valdecilla,OTHER,Phase 2,RECRUITING,2026-03-01,CMV,"(None, 0)",,,0.0,77
NCT06839118,Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache,Danish Headache Center,OTHER,Phase 3,RECRUITING,2026-03-01,Posttraumatic Headache,"(None, 0)",,,0.0,77
NCT07207382,"Clinical and Radiographic Evaluation of Three Biomimetic Materials in Pulp Therapy of Immature Young Permanent Teeth ""A Randomized Controlled Clinical Trial""",Ain Shams University,OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2026-03-01,Pulpotomy of Young Permanent Molars,"(None, 0)",,,0.0,77
NCT05978050,Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma,"Biotech Pharmaceutical Co., Ltd.",OTHER,Phase 3,RECRUITING,2026-03-01,Gastric or Esophagogastric Junction Adenocarcinoma,"(None, 0)",,,0.0,77
NCT06678074,"Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI",Implicit Bioscience,INDUSTRY,Phase 2,RECRUITING,2026-03-01,"STEMI, STEMI (ST Elevation MI), STEMI - ST Elevation Myocardial Infarction (MI)","(None, 0)",,,0.0,77
NCT06574880,STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer,"Angela Y. Jia, MD PhD",OTHER,Phase 2,RECRUITING,2026-03-01,"Malignant Neoplasm of Prostate, Locally Advanced Prostate Cancer","(None, 0)",,,0.0,77
NCT06063486,"Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms",University of Southern California,OTHER,Phase 2,RECRUITING,2026-03-01,"Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome","(None, 0)",,,0.0,77
NCT06289751,Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer,Tongji Hospital,OTHER,Phase 2,RECRUITING,2026-03-01,"Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy","(None, 0)",,,0.0,77
NCT06582940,Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis,Sun Yat-sen University,OTHER,Phase 2,RECRUITING,2026-03-01,"MRI-guided Adaptive Radiotherapy, Non-small Cell Lung Cancer, Brain Metastasis","(None, 0)",,,0.0,77
NCT06968000,Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,OTHER,Phase 2,RECRUITING,2026-03-01,"Inflammatory Response After Surgery, Postoperative Recovery","(None, 0)",,,0.0,77
NCT05648968,A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia,Novartis Pharmaceuticals,INDUSTRY,Phase 3,RECRUITING,2026-03-02,Warm Autoimmune Hemolytic Anemia (wAIHA),"('NVS', 100)",,,0.0,78
NCT06947330,Comparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical Mastectomy,Kholoud Usama,OTHER,Phase 3,RECRUITING,2026-03-03,"Modified Radical Mastectomy, Breast Cancer","(None, 0)",,,0.0,79
NCT05012254,Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases,Fundación GECP,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-03-15,"Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer","(None, 0)",,,0.0,91
NCT06781996,A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer,"Gustave Roussy, Cancer Campus, Grand Paris",OTHER,Phase 3,RECRUITING,2026-03-15,"Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)","(None, 0)",,,0.0,91
NCT00585507,Efficacy and Safety of 500mg of Fulvestrant,Beth Israel Deaconess Medical Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-03-15,Breast Cancer,"(None, 0)",,,0.0,91
NCT06116968,An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM,Corxel Pharmaceuticals,INDUSTRY,Phase 3,RECRUITING,2026-03-15,Obstructive Hypertrophic Cardiomyopathy,"('OLMA', 81)",,,0.0,91
NCT04455750,A Clinical Study Evaluating the Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant to Testosterone-Deprivation Therapy,Alliance for Clinical Trials in Oncology,OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2026-03-15,"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC V8","(None, 0)",,,0.0,91
NCT06301412,Combination of Hypothermia and Thrombectomy in Acute Stroke,University of Freiburg,OTHER,Phase 3,RECRUITING,2026-03-18,"Ischemic Stroke, Large Vessel Occlusion, Endovascular Treatment","(None, 0)",,,0.0,94
NCT06321289,Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL,Chinese PLA General Hospital,OTHER,Phase 2,RECRUITING,2026-03-20,"Non-hodgkin Lymphoma,B Cell","(None, 0)",,,0.0,96
NCT02399371,Pembrolizumab in Treating Patients With Malignant Mesothelioma,University of Chicago,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-03-20,"Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma","(None, 0)",,,0.0,96
NCT04498117,Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery,CanariaBio Inc.,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-03-26,"Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer","(None, 0)",,,0.0,102
NCT05180474,GEN1047 for Solid Tumors - First in Human (FIH) Trial,Genmab,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-03-26,"Breast Cancer, Breast Neoplasms, Endometrial Cancer, Endometrial Neoplasm, Ovarian Cancer, Ovarian Neoplasms","(None, 0)",,,0.0,102
NCT06768671,"An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)",MoonLake Immunotherapeutics AG,INDUSTRY,Phase 3,RECRUITING,2026-03-27,Hidradenitis Suppurativa,"(None, 0)",,,0.0,103
NCT04895696,A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE),Bristol-Myers Squibb,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-03-29,Systemic Lupus Erythematosus,"('BMY', 100)",,,0.0,105
NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors,Apollomics Inc.,INDUSTRY,Phase 2,RECRUITING,2026-03-30,"Solid Tumors, Advanced Cancer, Renal Cancer","(None, 0)",,,0.0,106
NCT05472337,Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome,Pontificia Universidad Catolica de Chile,OTHER,Phase 2,RECRUITING,2026-03-30,Acute Coronary Syndrome,"(None, 0)",,,0.0,106
NCT04791579,Antibiotic Prophylaxis for Neurogenic Bladder Botox,University of Alberta,OTHER,Phase 2,RECRUITING,2026-03-31,"Neurogenic Bladder, Post-operative Urinary Tract Infections","(None, 0)",,,0.0,107
NCT02629809,"Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia",M.D. Anderson Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-03-31,"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","(None, 0)",,,0.0,107
NCT06915246,A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma,VIVUS LLC,INDUSTRY,Phase 2,RECRUITING,2026-03-31,"Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma","(None, 0)",,,0.0,107
NCT05579639,Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant,"Children's Hospital Medical Center, Cincinnati",OTHER,Phase 2,RECRUITING,2026-03-31,Allogeneic Stem Cell Transplantation,"(None, 0)",,,0.0,107
NCT04952610,Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia,Milestone Pharmaceuticals Inc.,OTHER,Phase 3,ENROLLING_BY_INVITATION,2026-03-31,Paroxysmal Supraventricular Tachycardia,"('MIST', 100)",,,0.0,107
NCT06799234,Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003),University of Oxford,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-03-31,Rift Valley Fever,"(None, 0)",,,0.0,107
NCT05237388,Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease,Duke University,OTHER,Phase 2,RECRUITING,2026-03-31,Chronic Kidney Diseases,"(None, 0)",,,0.0,107
NCT05817903,Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients,Consorzio Oncotech,OTHER,Phase 2,RECRUITING,2026-04-01,Metastatic Renal Cell Carcinoma,"(None, 0)",,,0.0,108
NCT06122662,AMX0035 and Progressive Supranuclear Palsy,Amylyx Pharmaceuticals Inc.,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-04-01,"Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases","('ALNY', 87)",,,0.0,108
NCT06034938,DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road),"University Hospital, Caen",OTHER,Phase 2,RECRUITING,2026-04-01,Hiv,"(None, 0)",,,0.0,108
NCT06625398,"An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)","Viridian Therapeutics, Inc.",INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-04-01,Thyroid Eye Disease,"('VKTX', 88)",,,0.0,108
NCT07136077,A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy,M.D. Anderson Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-01,"Minimal Residual Disease, Adjuvant Chemotherapy, Colorectal Cancer","(None, 0)",,,0.0,108
NCT06305793,"RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)",Kanecia Obie Zimmerman,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-01,"Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19","(None, 0)",,,0.0,108
NCT05677451,"24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up",Novartis Pharmaceuticals,INDUSTRY,Phase 3,RECRUITING,2026-04-02,Chronic Spontaneous Urticaria,"('NVS', 100)",,,0.0,109
NCT06693908,"A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis","Genentech, Inc.",INDUSTRY,Phase 2,RECRUITING,2026-04-03,Moderate to Severe Ulcerative Colitis,"('RHHBY', 100)",,,0.0,110
NCT03107416,Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells,Memorial Sloan Kettering Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-05,Unresectable Hepatocellular Carcinoma,"(None, 0)",,,0.0,112
NCT05664191,Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage,Assistance Publique - Hôpitaux de Paris,OTHER,Phase 2,RECRUITING,2026-04-13,Sub-arachnoid Haemorrhage,"(None, 0)",,,0.0,120
NCT05992935,"Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","ModernaTX, Inc.",INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-14,Norovirus Acute Gastroenteritis,"('MRNA', 100)",,,0.0,121
NCT04292054,Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL),Assistance Publique - Hôpitaux de Paris,OTHER,Phase 3,RECRUITING,2026-04-18,Burns Surgery,"(None, 0)",,,0.0,125
NCT05718869,"Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study",City of Hope Medical Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-19,"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","(None, 0)",,,0.0,126
NCT06364384,Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma,"Sixth Affiliated Hospital, Sun Yat-sen University",OTHER,Phase 2,RECRUITING,2026-04-20,Rectal Squamous Cell Carcinoma,"(None, 0)",,,0.0,127
NCT06398405,A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer,Shandong Cancer Hospital and Institute,OTHER,Phase 2,RECRUITING,2026-04-22,"Esophageal Cancer, Dysphagia, Esophageal, Epigallocatechin Gallate","(None, 0)",,,0.0,129
NCT04696809,A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma,Janssen Pharmaceutical K.K.,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-22,Hematologic Malignancies,"(None, 0)",,,0.0,129
NCT06600789,A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies,Carrick Therapeutics Limited,INDUSTRY,Phase 2,RECRUITING,2026-04-22,Solid Malignancies,"(None, 0)",,,0.0,129
NCT06284434,Liposomal Bupivacaine Use in Alveolar Bone Graft Patients,Kerry O'Rourke,OTHER,Phase 3,RECRUITING,2026-04-24,Cleft Lip and Palate,"(None, 0)",,,0.0,131
NCT05354557,Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT),Memorial Sloan Kettering Cancer Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-26,Multiple Myeloma,"(None, 0)",,,0.0,133
NCT05488873,A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy,"WinSanTor, Inc",INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-26,Chemotherapy-induced Peripheral Neuropathy,"(None, 0)",,,0.0,133
NCT05715229,Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy,Hackensack Meridian Health,OTHER,Phase 2,RECRUITING,2026-04-28,"Carcinoma, Non-Small-Cell Lung","(None, 0)",,,0.0,135
NCT05231837,Neighborhood Park Youth Sports Program Fee Waiver and Intensive Family Outreach,University of Minnesota,OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2026-04-30,Physical Activity,"(None, 0)",,,0.0,137
NCT05147220,Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS),Novartis Pharmaceuticals,INDUSTRY,Phase 3,RECRUITING,2026-04-30,Relapsing Multiple Sclerosis,"('NVS', 100)",,,0.0,137
NCT06189742,Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS),Dr. Anne Ellis,OTHER,Phase 2,RECRUITING,2026-04-30,Asthma With Allergic Rhinitis,"(None, 0)",,,0.0,137
NCT03317392,Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis,National Cancer Institute (NCI),NIH,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-30,"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8","(None, 0)",,,0.0,137
NCT06367088,Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",OTHER,Phase 2,RECRUITING,2026-04-30,"Triple-negative Breast Cancer, Cadonilimab","(None, 0)",,,0.0,137
NCT04944979,"Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)",Kedrion S.p.A.,INDUSTRY,Phase 3,RECRUITING,2026-04-30,Primary Immunodeficiency Disease,"(None, 0)",,,0.0,137
NCT05153317,Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older,Vertex Pharmaceuticals Incorporated,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-04-30,Cystic Fibrosis,"('VRTX', 100)",,,0.0,137
NCT05270668,Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007),"Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-04-30,"Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease","('MRK', 100)",,,0.0,137
NCT07007949,a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia,The First Affiliated Hospital of Soochow University,OTHER,Phase 2,RECRUITING,2026-04-30,"Acute Myeloid Leukemia, IDH1 Gene Mutation, Ivosidenib","(None, 0)",,,0.0,137
NCT04469959,Dopaminergic Dysfunction in Late-Life Depression,Vanderbilt University Medical Center,OTHER,Phase 2,RECRUITING,2026-04-30,"Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant","(None, 0)",,,0.0,137
NCT06082635,TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC),"Shenzhen TargetRx, Inc.",INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-04-30,Non Small Cell Lung Cancer,"(None, 0)",,,0.0,137
NCT06951074,Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes,Ain Shams University,OTHER,Phase 3,RECRUITING,2026-05-01,"Stem Cells, Type 1 Diabetes","(None, 0)",,,0.0,138
NCT06924619,Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma,"Second Affiliated Hospital, School of Medicine, Zhejiang University",OTHER,Phase 2,RECRUITING,2026-05-01,Locally Advanced Thymoma,"(None, 0)",,,0.0,138
NCT02834013,Nivolumab and Ipilimumab in Treating Patients With Rare Tumors,National Cancer Institute (NCI),NIH,Phase 2,ACTIVE_NOT_RECRUITING,2026-05-01,"Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma","(None, 0)",,,0.0,138
NCT05540834,Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure,South West Sydney Local Health District,OTHER,Phase 2,RECRUITING,2026-05-01,"Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown","(None, 0)",,,0.0,138
NCT03917082,Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer,British Columbia Cancer Agency,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-05-01,"Breast Cancer Female, Hormone Receptor Positive Tumor","(None, 0)",,,0.0,138
NCT04274179,Ketogenic Diet for New-Onset Absence Epilepsy,Johns Hopkins University,OTHER,Phase 3,RECRUITING,2026-05-01,"Absence Epilepsy, Ketogenic Dieting, Epilepsy, Absence","(None, 0)",,,0.0,138
NCT04878094,A Study of Intra-operative Imaging in Women With Ovarian Cancer,Memorial Sloan Kettering Cancer Center,OTHER,Phase 3,RECRUITING,2026-05-03,"Ovarian Cancer, Ovarian Carcinoma","(None, 0)",,,0.0,140
NCT07212426,"Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.",Longbio Pharma,INDUSTRY,Phase 2,RECRUITING,2026-05-06,PNH - Paroxysmal Nocturnal Hemoglobinuria,"(None, 0)",,,0.0,143
NCT03288545,A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer,"Astellas Pharma Global Development, Inc.",INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-05-11,"Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms","(None, 0)",,,0.0,148
NCT05382442,A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer,Akeso,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-05-15,Metastatic Colorectal Cancer,"(None, 0)",,,0.0,152
NCT05133882,A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML,"Sunshine Lake Pharma Co., Ltd.",INDUSTRY,Phase 2,RECRUITING,2026-05-15,"Acute Myeloid Leukemia, Adult","(None, 0)",,,0.0,152
NCT06969807,Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease,Chinese PLA General Hospital,OTHER,Phase 2,RECRUITING,2026-05-15,Diabetic Kidney Disease (DKD),"(None, 0)",,,0.0,152
NCT05049057,Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI,Henry M. Jackson Foundation for the Advancement of Military Medicine,OTHER,Phase 2,RECRUITING,2026-05-19,"Posttraumatic Headache, Mild Traumatic Brain Injury","(None, 0)",,,0.0,156
NCT04009499,"A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis",UCB Biopharma SRL,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-05-25,Psoriatic Arthritis,"(None, 0)",,,0.0,162
NCT02094794,Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML,City of Hope Medical Center,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-05-26,"Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)","(None, 0)",,,0.0,163
NCT07054034,Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects,Shanghai Mabgeek Biotech.Co.Ltd,OTHER_GOV,Phase 2,ACTIVE_NOT_RECRUITING,2026-05-26,Bronchial Asthma,"(None, 0)",,,0.0,163
NCT04055649,ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer,Ira Winer,OTHER,Phase 2,RECRUITING,2026-05-28,"Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma","(None, 0)",,,0.0,165
NCT05591677,D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT),The Alfred,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-05-29,Major Depressive Disorder,"(None, 0)",,,0.0,166
NCT03847428,Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment,AstraZeneca,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-05-29,Hepatocellular Carcinoma,"('AZN', 100)",,,0.0,166
NCT07207408,"Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age",Dynavax Technologies Corporation,INDUSTRY,Phase 2,RECRUITING,2026-05-29,Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis,"('DGXA', 100)",,,0.0,166
NCT04669171,"A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma",Enterome,INDUSTRY,Phase 2,RECRUITING,2026-05-30,"Follicular Lymphoma, Marginal Zone Lymphoma","(None, 0)",,,0.0,167
NCT04817007,A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis),Bristol-Myers Squibb,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-05-31,Myelofibrosis,"('BMY', 100)",,,0.0,168
NCT06747312,Effect of Belimumab on Antibody Titers in Primary APS Patients,Ruijin Hospital,OTHER,Phase 2,RECRUITING,2026-05-31,Antiphospholipid Syndrome (APS),"(None, 0)",,,0.0,168
NCT04932577,Faecal Microbiota Transplantation for Liver Cirrhosis,University of Aarhus,OTHER,Phase 3,RECRUITING,2026-05-31,Liver Cirrhosis,"(None, 0)",,,0.0,168
NCT04335656,Reducing Innate Inflammation in New Onset Type 1 Diabetes,Medical College of Wisconsin,OTHER,Phase 2,ACTIVE_NOT_RECRUITING,2026-05-31,"Type 1 Diabetes, type1diabetes, Type 1 Diabetes Mellitus","(None, 0)",,,0.0,168
NCT03697356,R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia,Kosin University Gospel Hospital,OTHER,Phase 2,RECRUITING,2026-05-31,Waldenström's Macroglobulinemia,"(None, 0)",,,0.0,168
NCT05312879,Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease,Vertex Pharmaceuticals Incorporated,INDUSTRY,Phase 3,RECRUITING,2026-05-31,Proteinuric Kidney Disease,"('VRTX', 100)",,,0.0,168
NCT04084080,Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE),University of Pittsburgh,OTHER,Phase 3,ACTIVE_NOT_RECRUITING,2026-05-31,Sickle Cell Disease,"(None, 0)",,,0.0,168
NCT06797401,Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia,Ribocure Pharmaceuticals AB,INDUSTRY,Phase 2,RECRUITING,2026-05-31,Dyslipidemias,"(None, 0)",,,0.0,168
NCT07008885,BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL,Chinese PLA General Hospital,OTHER,Phase 2,RECRUITING,2026-05-31,Acute Lymphocytic Leukemia,"(None, 0)",,,0.0,168
NCT06347718,CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease,Miltenyi Biomedicine GmbH,INDUSTRY,Phase 2,RECRUITING,2026-05-31,"Systemic Lupus Erythematosus, Systemic Sclerosis, Dermatomyositis","(None, 0)",,,0.0,168
NCT03907475,"Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial",National Cancer Institute (NCI),NIH,Phase 2,RECRUITING,2026-06-01,"Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm","(None, 0)",,,0.0,169
NCT05845723,Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome,Peking Union Medical College Hospital,OTHER,Phase 2,RECRUITING,2026-06-01,"Aneurysm, Behcet Syndrome, Vascular Type","(None, 0)",,,0.0,169
NCT05345002,All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma,"Stephen Bagley, MD, MSCE",OTHER,Phase 2,RECRUITING,2026-06-01,"Glioma, IDH Mutation, Astrocytoma","(None, 0)",,,0.0,169
NCT04888312,Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients,Alligator Bioscience AB,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-06-01,Metastatic Pancreatic Ductal Adenocarcinoma,"(None, 0)",,,0.0,169
NCT03922542,Comparison of Standard vs. Accelerated Corneal Crosslinking,Price Vision Group,INDUSTRY,Phase 3,RECRUITING,2026-06-01,"Keratoconus, Ectasia Corneal","(None, 0)",,,0.0,169
NCT06015659,ZN-c3 + Gemcitabine in Pancreatic Cancer,"Brandon Huffman, MD",OTHER,Phase 2,RECRUITING,2026-06-01,"Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma","(None, 0)",,,0.0,169
NCT06510699,Pharmacogenomics for Better Treatment of Fungal Infections in Cancer,The University of Queensland,OTHER,Phase 2,RECRUITING,2026-06-01,"Fungal Infection, Haematological Malignancy, Blood Cancer","(None, 0)",,,0.0,169
NCT06211634,"A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia",Hemab ApS,INDUSTRY,Phase 2,ACTIVE_NOT_RECRUITING,2026-06-01,Glanzmann Thrombasthenia,"(None, 0)",,,0.0,169
NCT04472767,Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma,"University of California, Irvine",OTHER,Phase 2,RECRUITING,2026-06-01,"Hepatocellular Carcinoma, HCC","(None, 0)",,,0.0,169
NCT04493164,CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome,M.D. Anderson Cancer Center,OTHER,Phase 2,RECRUITING,2026-06-01,"Acute Myeloid Leukemia With Gene Mutations, Myelodysplastic Syndrome, Myeloproliferative Neoplasm","(None, 0)",,,0.0,169
NCT06064929,A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old,"HI-Bio, A Biogen Company",INDUSTRY,Phase 2,RECRUITING,2026-06-01,Lupus Nephritis,"('BIIB', 100)",,,0.0,169
NCT05835505,Detoxification of the Liver In PSC (Dolphin),Brigham and Women's Hospital,OTHER,Phase 2,RECRUITING,2026-06-01,Primary Sclerosing Cholangitis,"(None, 0)",,,0.0,169
NCT06534411,"A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both",Novo Nordisk A/S,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-06-02,"Diabetes Mellitus, Type 2","(None, 0)",,,0.0,170
NCT04550260,Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC,AstraZeneca,INDUSTRY,Phase 3,ACTIVE_NOT_RECRUITING,2026-06-02,Esophageal Squamous Cell Carcinoma,"('AZN', 100)",,,0.0,170
NCT05957913,Effects of Antiviral Therapies on Epstein-Barr Virus Replication,Massachusetts General Hospital,OTHER,Phase 2,ENROLLING_BY_INVITATION,2026-06-04,Multiple Sclerosis,"(None, 0)",,,0.0,172
NCT03584165,Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa,"NightstaRx Ltd, a Biogen Company",OTHER,Phase 3,ENROLLING_BY_INVITATION,2026-06-04,"Choroideremia, X-Linked Retinitis Pigmentosa","('BIIB', 100)",,,0.0,172
NCT05714969,A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP),Takeda,INDUSTRY,Phase 2,RECRUITING,2026-06-11,Thrombotic Thrombocytopenic Purpura (TTP),"(None, 0)",,,0.0,179
